Related Experiment Videos
Adverse events associated with paediatric use of complementary and alternative medicine: Results of a Canadian
Sunita Vohra1, Jayna Brulotte, Christopher Le
1University of Alberta, Edmonton, Alberta.
Insights
Serious adverse events from pediatric complementary and alternative medicine (CAM) are rare, but delays in diagnosis or treatment are more common. Pediatricians should routinely ask about CAM use to ensure patient safety.
Area of Science:
- Pediatric Health
- Integrative Medicine
- Patient Safety
Background:
- Complementary and alternative medicine (CAM) use in children is prevalent.
- Limited data exists on adverse events associated with pediatric CAM use.
Purpose of the Study:
- To determine the frequency and severity of adverse events linked to pediatric CAM utilization.
- To assess the impact of CAM on diagnosis and treatment timelines in children.
Main Methods:
- A national survey was conducted in January 2006.
- The Canadian Paediatric Surveillance Program distributed surveys to all Canadian pediatricians and subspecialists.
- Survey questions were developed through literature review and expert consultation.
Main Results:
- 23% of surveyed pediatricians responded.
- Pediatricians inquired about CAM use in 38% of cases; patients disclosed use proactively only 22% of the time.
- 7% of respondents reported adverse events, primarily from natural health products. 18% reported delayed diagnosis or treatment attributed to CAM.
Conclusions:
- Serious adverse events from pediatric CAM appear infrequent, but delays in diagnosis or treatment are more common.
- Under-reporting of adverse events is likely due to limited pediatrician-patient discussion about CAM.
- Active surveillance is necessary to accurately assess pediatric CAM-related adverse events, and routine inquiry by pediatricians is recommended for patient safety.
Background:
Despite many studies confirming that the use of complementary and alternative medicine (CAM) by children is common, few have assessed related adverse events.
Objective:
To conduct a national survey to identify the frequency and severity of adverse events associated with paediatric CAM use.
Methods:
Survey questions were developed based on a review of relevant literature and consultation with content experts. In January 2006, the Canadian Paediatric Surveillance Program distributed the survey to all paediatricians and paediatric subspecialists in active practice in Canada.
Results:
Of the 2489 paediatricians who received the survey, 583 (23%) responded. Respondents reported that they asked patients about CAM use 38% of the time and that patients disclosed this information before being questioned only 22% of the time. Forty-two paediatricians (7%) reported seeing adverse events, most commonly involving natural health products, in the previous year. One hundred five paediatricians (18%) reported witnessing cases of delayed diagnosis or treatment (n=488) that they attributed to the use of CAM.
Conclusion:
While serious adverse events associated with paediatric CAM appear to be rare, delays in diagnosis or treatment seem more common. Given the lack of paediatrician-patient discussion regarding CAM use, our findings may under-represent adverse events. A lack of reported adverse events should not be interpreted as a confirmation of safety. Active surveillance is required to accurately assess the incidence, nature and severity of paediatric CAM-related adverse events. Patient safety demands that paediatricians routinely inquire about the use of CAM.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution